A detailed history of Pingora Partners LLC transactions in Scynexis Inc stock. As of the latest transaction made, Pingora Partners LLC holds 12,000 shares of SCYX stock, worth $10,440. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,000
Holding current value
$10,440
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.9 - $1.41 $10,800 - $16,920
12,000 New
12,000 $11.4 Million

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $28.4M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Pingora Partners LLC Portfolio

Follow Pingora Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pingora Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pingora Partners LLC with notifications on news.